Cefdinir
- Product NDC
- 68071-2503
- 11-digit product format
- 680712503
- Labeler code
- 68071
- Product ID
- 68071-2503_2badf51d-00cc-a56f-e063-6394a90a004d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA210220
- Marketing category
- ANDA
- Marketing start
- 2021-02-20
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefdinir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFDINIR | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | CI0FAO63WC |
| Rxcui | 200346 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2503-2 | Cefdinir | 20 in 1 BOTTLE | CAPSULE | 20 | | 3 |
| 68071-2503-3 | Cefdinir | 30 in 1 BOTTLE | CAPSULE | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2503 | CEFDINIR CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 2 package rows | 20250116_c974d975-8616-3551-e053-2995a90a65f3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2503-2 | 68071250302 | 20 CAPSULE in 1 BOTTLE (68071-2503-2) | 20 capsule | 2021-02-20 | 0000-00-00 | No | No | Current |
| 68071-2503-3 | 68071250303 | 30 CAPSULE in 1 BOTTLE (68071-2503-3) | 30 capsule | 2025-01-14 | | No | No | Current |